摘要
目的探讨安体舒通对糖尿病(DM)大鼠肾脏Nephrin蛋白表达的影响。方法 SD大鼠分为对照组、糖尿病肾病(DN)组、安体舒通组。腹腔注射链脲佐菌素(50 mg/kg)建立糖尿病大鼠模型,实验12周末检测肾功能、蛋白尿、脂蛋白,Western Blot检测足细胞Nephrin蛋白含量(P<0.05)。结果较安体舒通组,DN组大鼠尿素氮(BUN)、血肌酐(Ccr)下降,24 h尿微量白蛋白排泄率(UAER)增多,脂蛋白升高,且肾脏Nephrin蛋白表达下调,差异有显著性意义(P<0.05)。结论安体舒通对糖尿病肾病肾功能有保护作用,其机制可能与其上调Nephrin蛋白有关。
Objective To observe the effects of spironolactone on the expression of nephrin in the kidney of diabetic ne -phrophathy rats.Methods Healthy male Sprague-Dawley(SD)rats were randomly divided into normal control (NC) and experimental groups .Rat models of diabetic nephropathy were established by intraperitoneal injection of streptozotocin ;After the modeling, the experimental group were randomly divided into diabetic nephrophathy ( DN) group and spironolactone group.At the end of 12th week, blood urea nitrogen(BUN), creatinine clearance rate(Ccr), 24h urine protein(24hUpro) and lipoprotein A were determined , the expression level of Nephrin protein was observed by western blot .Results Com-pared with spironolactone groups , BUN, Ccr,24Upro and lipoprotein A in DN group statistically increased;the expression level of nephrin protein in spironolactone group was increased compared with DN group .Conclusion Spironolactone can im-prove the renal function of rats with diabetic nephropathy .Its mechanism may be ralited to the increasing of nephrin expres-sion.
出处
《大连医科大学学报》
CAS
2014年第4期332-334,共3页
Journal of Dalian Medical University
基金
湖北省教育厅科学技术研究项目(B20112114)
十堰市科技局科研项目(2009s09)